monitoring of MLD, using a noninvasive lymphoproliferation assay, may be used to assess the clinical status of patients at different stages of treatment and could potentially improve risk assessment strategies in the management of ALL. We recommend that patients with low MLD should be closely monitored for disease resurgence. Additionally, low-dose therapy may be considered for patients showing a persisting high MLD (8 g). Comparison of lymphoproliferation assay with PCR, immunophenotyping and cytomorphological studies, in a large study population, would further validate its application as a novel strategy in ALL research. Such studies are currently underway.
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Coronaric thrombotic events in acute promyelocytic leukemia during all-trans retinoic acid treatment: a role for adhesion molecules overexpression?
TO THE EDITOR Over recent years much evidence has indicated that acute myocardial syndrome recognizes a multifactorial pathogenesis. In particular, a role has been found for inflammation and coronaric thrombosis. 1 As concerns this issue, we report an observation made in acute promyelocytic leukemia (APL) patients. APL is a rare subtype of acute myeloid leukemia (AML) characterized by a unique response to all-trans retinoic acid (ATRA) treatment, with a complete remission (CR) rate higher than 80%. 2 Among 17 elderly APL patients (aged more than 60 years) treated at our Institution over 5 years with ATRA ± chemotherapy, 15 (88.2%) achieved a CR. However, we observed four coronaric thrombotic events: two fatal acute myocardial infarctions (AMI) after 18 and 19 days and two unstable angina after 20 and 22 days from ATRA initiation. When thrombotic events occurred, patients were thrombocytopenic (three with platelets less than 20 × 10 9 /l and one with platelets equal to 75 × 10 9 /l); the coagulative profile was normal and WBC were more than 25 × 10 9 /l in patients with AML, while patients with unstable angina were leukopenic (WBC Ͻ1.0 × 10 9 /l). It is well known that platelets are a major risk factor for arterial thrombosis but all four patients were thrombocytopenic when the arterial thrombotic event occurred and these events only affected coronaric area. Therefore a role in the pathogenesis of these cardiac thrombotic events might be due to a thrombophilic effect of ATRA. In fact, although ATRA administration promptly corrects the coagulopathy present in APL, a persistent procoagulant tendency continues to act dur- ing ATRA treatment. 3 Some authors referred to an increased expression of adhesion molecules such as VCAM, CD11a, CD11b in polymorphonuclear cells from coronaric sinus of patients with unstable angina. 4 Whether this phenomenon might be primitive (and thus potentially crucial in the destabilization of an atheromasic plaque) or secondary to a disreactive, as well as inflammatory status, is at present unknown. In vitro studies indicate that ATRA is capable of inducing in APL cells the expression of the same adhesion molecules which have been locally found overexpressed in patients with unstable angina. 5 If this overexpression receives an in vivo confirmation during ATRA treatment, ATRA in APL patients could be responsible in predisposing patients to pathologic conditions similar to those observed during unstable angina.
C Torromeo
Department [1] [2] [3] The rearrangement of the T cell receptor (TCR) gene is considered to be the hallmark of clonality and the proof of 'leukemia', which is distinguished from reactive increase of LGL. We report a very rare case of the spontaneous remission of LGL T cell leukemia.
The patient, a 71-year-old man, was referred to us because of bacterial pneumonia and lymphocytosis in March 1993. Hematologic data on admission included a hemoglobin level of 9.5 g/dl, a platelet count of 64 × 10 9 /l, and a white blood cell count of 39 × 10 9 /l including 59% lymphocytes. Cytometric analysis of a bone marrow aspirate showed a hypercellular marrow with 66% lymphocytes. Bone marrow cytogenetic studies were normal. Most lymphocytes in both peripheral blood and bone marrow were small or mediumsized mature lymphocytes without nuclear atypia, possessing abundant cytoplasm with azurophilic granules. Cell-surface marker analysis demonstrated expression of CD3 (Ͼ90%), CD7 (31%) and CD8 (72%); CD4 was not expressed. DNA analysis by Southern blotting showed rearrangement of the T cell receptor (TCR) beta chain gene (Figure 1 ). Antibodies to HTLV-1 were not detected. These findings were consistent with LGL T cell leukemia. No lymphadenopathy or organomegaly were detected by physical examination and computed tomography. The patient was only treated with antibiotics, resulting in resolution of the pneumonia. His lymphocyte counts gradually decreased to within the normal range 4 months after onset. Hematologic data showed no abnormality, without neutropenia nor anemia. The TCR gene rearrangement was not detected at re-examination after 4 years ( Figure 1) . The patient died due to aspiration pneumonia after right femur neck fracture in May 1998. Necropsy specimen of bone marrow revealed no evidence of LGL leukemia.
Although increased numbers of LGL are seen in the peripheral blood during viral infections, after myocardial infarction, and during recovery from bone marrow transplantation, LGL leukemia is distinguished from such reactive LGL proliferations by the possession of a marker of clonality.
1,4 Our patient showed cytotoxic T cell markers and TCR beta gene rearrangement, findings compatible with LGL T cell leukemia. Most patients with LGL T cell leukemia have an indolent clinical course, with morbidity related to neutropenia rather than tumor burden; occasional cases follow a more aggressive clinical course. 
Figure 1
Southern blot analysis of DNAs from peripheral blood of the patient at diagnosis and at remission. DNAs digested with EcoRV and BamHI were hybridized with a TCR beta chain probe. The migration of rearranged (arrows) and germ line (arrowheads) DNA are indicated.
described, 2 only one occurrence of spontaneous remission of LGL T cell leukemia has been reported; that patient still showed evidence of a persistent clone by Southern blot analysis, and later developed clinical relapse characterized by neutropenia and anemia. 3, 6 Our case might represent a very rare instance of spontaneous 'cytogenetic' remission or spontaneous cure of LGL T cell leukemia. On the other hand, some possibility remains that this case could be a reactive LGL proliferative disorder, even though clonal in nature.
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